Aliases for CIITA Gene
- Class II, Major Histocompatibility Complex, Transactivator 2 3
- MHC2TA 3 4 6
- MHC Class II Transactivator 2 3
- C2TA 3 6
- Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Acid Domain Containing 3
- Leucine Rich Repeat And Acid Domain Containing 2
- Nucleotide-Binding Oligomerization Domain 2
- MHC Class II Transactivator Type III 3
External Ids for CIITA Gene
Previous Symbols for CIITA Gene
This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
GeneCards Summary for CIITA Gene
CIITA (Class II, Major Histocompatibility Complex, Transactivator) is a Protein Coding gene. Diseases associated with CIITA include staphylococcal toxic shock syndrome and mhc class ii deficiency. Among its related pathways are Interferon Signaling and Interferon Signaling. GO annotations related to this gene include transcription coactivator activity and protein C-terminus binding. An important paralog of this gene is NLRX1.
UniProtKB/Swiss-Prot for CIITA Gene
Essential for transcriptional activity of the HLA class II promoter; activation is via the proximal promoter. No DNA binding of in vitro translated CIITA was detected. May act in a coactivator-like fashion through protein-protein interactions by contacting factors binding to the proximal MHC class II promoter, to elements of the transcription machinery, or both. Alternatively it may activate HLA class II transcription by modifying proteins that bind to the MHC class II promoter. Also mediates enhanced MHC class I transcription; the promoter element requirements for CIITA-mediated transcription are distinct from those of constitutive MHC class I transcription, and CIITA can functionally replace TAF1 at these genes. Exhibits intrinsic GTP-stimulated acetyltransferase activity. Exhibits serine/threonine protein kinase activity: can phosphorylate the TFIID component TAF7, the RAP74 subunit of the general transcription factor TFIIF, histone H2B at Ser-37 and other histones (in vitro).